Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Buy Us a Coffee
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2024-13972
Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
A vulnerability related to registry permissions in the Intercept X for Windows updater prior to Core Agent version 2024.3.2 can lead to a local user gaining SYSTEM level privileges during a product upgrade.
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Source: NVD (National Vulnerability Database)
Vulnerability Type
缺省权限不正确
Source: NVD (National Vulnerability Database)
Vulnerability Title
Sophos Intercept X 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Sophos Intercept X是英国Sophos公司的一种端点保护。可防止未知恶意软件、漏洞利用和勒索软件。 Sophos Intercept X 2024.3.2之前版本存在安全漏洞，该漏洞源于注册表权限处理不当，可能导致本地用户在升级过程中获取SYSTEM权限。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
SophosSophos Intercept X for Windows Core Agent 0 ~ 2024.3.2 -
II. Public POCs for CVE-2024-13972
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2024-13972
Please Login to view more intelligence information
IV. Related Vulnerabilities
Same vendor: Sophos
Same weakness: CWE-276
V. Comments for CVE-2024-13972

No comments yet

Leave a comment